Drug Intervention of Spontaneous Hyperventilation in Patients With Aneurysmal Subarachnoid Hemorrhage
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
Although spontaneous hyperventilation patients with aneurysmal subarachnoid hemorrhage
closely associated with poor outcomes, the standard therapy remains unavailable. Remifentanil
has the pharmacological characterization of respiratory inhibition, mainly prolonging the
expiratory time and decreasing the respiratory rate while preserving the respiratory drive.
The investigators hypothesis that spontaneous hyperventilation could be corrected by
titrating the dose of remifentanil and cerebral blood flow will augment during this process.